Catheter ablation of idiopathic ventricular tachycardia without the use of fluoroscopy.
BACKGROUND
Catheter ablation is the treatment of choice for many patients with idiopathic ventricular tachycardia (VT). Unfortunately, conventional catheter ablation is guided by fluoroscopy, which is associated with a small but definite radiation risk for patients and laboratory personnel. The aim of our study is to assess feasibility, success rate and safety of idiopathic VT ablation procedure performed without the use of fluoroscopy.


METHODS
Nineteen consecutive patients undergoing idiopathic VT ablation at our institution have been included. The ablation procedures were performed under the guidance of electroanatomical mapping (EAM) system and intracardiac echocardiography (ICE).


RESULTS
Nineteen patients (mean age 38.7 years) underwent ablation procedure for idiopathic VT. Twelve (63%) had outflow tract VT, 3 (18%) fascicular tachycardia, 2 (11%) peri-tricuspidal VT, 1 (5%) peri-mitral VT, and 1 (5%) lateral left free-wall VT. The mean procedural time was 170.2 ± 45.7 min. No fluoroscopy was used in any procedural phase. Acute success rate was 100%. No complication was documented in any patients. After a mean follow up of 18 ± 4 months, recurrences occurred in 2 patients.


CONCLUSIONS
In our preliminary experience idiopathic VT ablation without the use of fluoroscopy was feasible and safe, using a combination of EAM and ICE. Success rate was excellent with no complication.
Department of Medicine, Cardiovascular Section, San Eugenio Hospital, Rome, Italy. Electronic address: filippo.lamberti@tin.it.
Filippo
F
Lamberti
Department of Medicine, Cardiovascular Section, San Eugenio Hospital, Rome, Italy.
Francesca
F
Di Clemente
Department of Medicine, Cardiovascular Section, San Eugenio Hospital, Rome, Italy.
Romolo
R
Remoli
Department of Medicine, Cardiovascular Section, San Eugenio Hospital, Rome, Italy.
Cesare
C
Bellini
Department of Medicine, Cardiovascular Section, San Eugenio Hospital, Rome, Italy.
Antonella
A
De Santis
Biosense Webster Italy, Johnson and Johnson Medical, Milan, Italy.
Marina
M
Mercurio
Biosense Webster Italy, Johnson and Johnson Medical, Milan, Italy.
Serena
S
Dottori
Department of Medicine, Cardiovascular Section, San Eugenio Hospital, Rome, Italy.
Achille
A
Gaspardone
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017115:Catheter Ablation / Q000379:methods*; D005260:Female; D005471:Fluoroscopy; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D017180:Tachycardia, Ventricular / Q000175:diagnosis* / Q000601:surgery*; D055815:Young Adult
Electro-anatomical mapping; Idiopathic ventricular tachycardia; Intracardiac echocardiography; Non-fluoroscopic catheter ablation; Radiation risk; Radiofrequency